APA (7th ed.) Citation

Jun-Feng Li, Xiang Qu, Zhan Gao, Chang-Xi Chen, Feng-Yu Zhang, Ling Cheng, . . . Hao Zhou. (2023). Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jun-Feng Li, Xiang Qu, Zhan Gao, Chang-Xi Chen, Feng-Yu Zhang, Ling Cheng, Xi Zhou, and Hao Zhou. Association Between Dosing of Spironolactone and Outcomes in Heart Failure with Preserved Ejection Fraction Patients Combined with Chronic Kidney Disease------Balance of Efficacy and Risk. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Jun-Feng Li, et al. Association Between Dosing of Spironolactone and Outcomes in Heart Failure with Preserved Ejection Fraction Patients Combined with Chronic Kidney Disease------Balance of Efficacy and Risk. Frontiers Media S.A., 2023.